{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:06:06Z","timestamp":1791533166741,"version":"4.3.4"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute, Italy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Rome Tor Vergata"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.steroids.2014.05.001","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T23:00:30Z","timestamp":1399676430000},"page":"46-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Mineralocorticoid receptor in adipocytes and macrophages: A promising target to fight metabolic syndrome"],"prefix":"10.1016","volume":"91","author":[{"given":"Vincenzo","family":"Marzolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Armani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Feraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo U.","family":"De Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Caprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2014.05.001_b0005","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nrendo.2009.106","article-title":"Stress and disorders of the stress system","volume":"5","author":"Chrousos","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.steroids.2014.05.001_b0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.med.48.1.231","article-title":"Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance","volume":"48","author":"Funder","year":"1997","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.steroids.2014.05.001_b0015","doi-asserted-by":"crossref","first-page":"525093","DOI":"10.1155\/2012\/525093","article-title":"Glucocorticoids and type 2 diabetes: from physiology to pathology","volume":"2012","author":"Di Dalmazi","year":"2012","journal-title":"J Nutr Metab"},{"key":"10.1016\/j.steroids.2014.05.001_b0020","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1146\/annurev.ph.54.030192.004321","article-title":"Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis","volume":"54","author":"Pilkis","year":"1992","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.steroids.2014.05.001_b0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.2012.06597.x","article-title":"Visceral adipose tissue: emerging role of gluco-and mineralocorticoid hormones in the setting of cardiometabolic alterations","volume":"1264","author":"Boscaro","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.steroids.2014.05.001_b0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.1123348","article-title":"Evolution of hormone-receptor complexity by molecular exploitation","volume":"312","author":"Bridgham","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.steroids.2014.05.001_b0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.2009.04988.x","article-title":"Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders","volume":"1179","author":"Chrousos","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.steroids.2014.05.001_b0040","doi-asserted-by":"crossref","first-page":"F181","DOI":"10.1152\/ajprenal.2001.280.2.F181","article-title":"Multiple aspects of mineralocorticoid selectivity","volume":"280","author":"Farman","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.steroids.2014.05.001_b0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1742-2094-9-260","article-title":"Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells","volume":"9","author":"Chantong","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.steroids.2014.05.001_b0050","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM196511182732106","article-title":"Hypertension, the potassium ion and impaired carbohydrate tolerance","volume":"273","author":"Conn","year":"1965","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.05.001_b0055","first-page":"755","article-title":"Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism?","volume":"8","author":"Shimamoto","year":"1994","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.steroids.2014.05.001_b0060","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.05.001_b0065","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/157016112799304969","article-title":"Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists","volume":"10","author":"Ronconi","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.steroids.2014.05.001_b0070","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCULATIONAHA.107.708537","article-title":"Multi marker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study","volume":"116","author":"Ingelsson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2014.05.001_b0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.numecd.2008.06.001","article-title":"Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity","volume":"19","author":"Dall\u2019Asta","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.steroids.2014.05.001_b0080","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1210\/en.2011-1176","article-title":"The development of hypertension and hyperaldosteronism in a rodent model of life-long obesity","volume":"153","author":"Northcott","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.05.001_b0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.mce.2011.09.011","article-title":"The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism","volume":"350","author":"Marzolla","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.steroids.2014.05.001_b0090","doi-asserted-by":"crossref","first-page":"14211","DOI":"10.1073\/pnas.2336140100","article-title":"Human adipocytes secrete mineralocorticoid-releasing factors","volume":"100","author":"Ehrhart-Bornstein","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.steroids.2014.05.001_b0095","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","article-title":"Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction","volume":"59","author":"Briones","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.05.001_b0100","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2014.05.001_b0105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice","volume":"84","author":"Hirata","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.steroids.2014.05.001_b0110","doi-asserted-by":"crossref","unstructured":"Armani A, Cinti F, Marzolla V, Morgan J, Cranston GA, Antelmi A, Carpinelli G, Canese R, Pagotto U, Quarta C, Malorni W, Matarrese P, Marconi M, Rosano G, Fabbri A, Young MJ, Caprio M. Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high fat diet-fed mice. FASEB J 2014 [Epub ahead of print].","DOI":"10.1096\/fj.13-245415"},{"key":"10.1016\/j.steroids.2014.05.001_b0115","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1292\/jvms.12-0007","article-title":"Spironolactone, but not eplerenone, impairs glucose tolerance in a rat model of metabolic syndrome","volume":"74","author":"Homma","year":"2012","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.steroids.2014.05.001_b0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2003.10.009","article-title":"Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies","volume":"217","author":"Pitt","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.steroids.2014.05.001_b0125","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2014.05.001_b0130","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.05.001_b0135","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.05.001_b0140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2014.05.001_b0145","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.104.501502","article-title":"Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension","volume":"112","author":"White","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2014.05.001_b0150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.HYP.0000232179.60442.84","article-title":"Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension","volume":"48","author":"White","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.05.001_b0155","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/01.gme.0000243572.63322.f7","article-title":"Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide","volume":"14","author":"Preston","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.steroids.2014.05.001_b0160","first-page":"1816","article-title":"Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.05.001_b0165","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.gme.0000177318.24005.b1","article-title":"Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial","volume":"12","author":"Archer","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.steroids.2014.05.001_b0170","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/09513590701582323","article-title":"Advances in hormone replacement therapy: weight benefits of drospirenone, a 17alpha-spirolactone-derived progestogen","volume":"23","author":"Foidart","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.steroids.2014.05.001_b0175","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2796.2005.01571.x","article-title":"Effects of 17beta-oestradiol plus different doses of drospirenone on adipose tissue, adiponectin and atherogenic metabolites in postmenopausal women","volume":"258","author":"Tanko","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.steroids.2014.05.001_b0180","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/en.2010-0674","article-title":"Anti adipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome","volume":"152","author":"Caprio","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.05.001_b0185","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.d2139","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database","volume":"342","author":"Parkin","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.steroids.2014.05.001_b0190","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","article-title":"Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data","volume":"342","author":"Jick","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.steroids.2014.05.001_b0195","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2337\/dc08-1709","article-title":"Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program","volume":"32","author":"Preiss","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.steroids.2014.05.001_b0200","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.metabol.2012.08.011","article-title":"Effect of low dose mineralocorticoid receptor antagonist eplerenone on glucose and lipid metabolism in healthy adult males","volume":"62","author":"Krug","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.steroids.2014.05.001_b0205","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/dom.12224","article-title":"Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects","volume":"16","author":"Garg","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.steroids.2014.05.001_b0210","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1517\/14656566.2013.832756","article-title":"Effects of canrenone in patients with metabolic syndrome","volume":"14","author":"Derosa","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.steroids.2014.05.001_b0215","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI114345","article-title":"Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium","volume":"84","author":"Hauner","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.05.001_b0220","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1210\/endo.132.6.8504747","article-title":"Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes","volume":"132","author":"Rondinone","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.05.001_b0225","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.steroids.2014.05.001_b0230","doi-asserted-by":"crossref","unstructured":"Armani A, Marzolla V, Rosano G, Caprio M. Mineralocorticoid vs glucocorticoid receptors: solo players or team mates in the control of adipogenesis? Int J Obes 2014 [Epub ahead of print].","DOI":"10.1038\/ijo.2014.68"},{"key":"10.1016\/j.steroids.2014.05.001_b0235","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2014.05.001_b0240","doi-asserted-by":"crossref","first-page":"E977","DOI":"10.1152\/ajpendo.00561.2001","article-title":"Mouse models of insulin resistance","volume":"282","author":"Hribal","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.05.001_b0245","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMc0910718","article-title":"Tumor necrosis factor alpha and regulation of adipose tissue","volume":"362","author":"Arner","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.05.001_b0250","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.05.001_b0255","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1096\/fj.05-5678fje","article-title":"Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression","volume":"20","author":"Jernas","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.steroids.2014.05.001_b0260","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1210\/jc.2006-1055","article-title":"Relationship between adipocyte size and adipokine expression and secretion","volume":"92","author":"Skurk","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.05.001_b0265","doi-asserted-by":"crossref","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","article-title":"A novel serum protein similar to C1q, produced exclusively in adipocytes","volume":"270","author":"Scherer","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2014.05.001_b0270","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1043-2760(01)00524-0","article-title":"ACRP30\/adiponectin: an adipokine regulating glucose and lipid metabolism","volume":"13","author":"Berg","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.05.001_b0275","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1152\/ajpendo.00323.2013","article-title":"Paradoxical resistance to high-fat diet-induced obesity and altered macrophage polarization in mineralocorticoid receptor-overexpressing mice","volume":"306","author":"Kuhn","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.05.001_b0280","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mce.2003.10.045","article-title":"Expression and function of the human mineralocorticoid receptor: lessons from transgenic mouse models","volume":"217","author":"Le Menuet","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.steroids.2014.05.001_b0285","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJM198104163041602","article-title":"The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients","volume":"304","author":"Tuck","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.05.001_b0290","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jsbmb.2013.02.012","article-title":"Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity","volume":"137","author":"Feraco","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2014.05.001_b0295","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/sj.ijo.0803642","article-title":"Human adipocytes induce an ERK1\/2 MAP kinases-mediated upregulation of steroidogenic acute regulatory protein (StAR) and an angiotensin II-sensitization in human adrenocortical cells","volume":"31","author":"Krug","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.steroids.2014.05.001_b0300","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1096\/fj.07-9412com","article-title":"A novel adipokine CTRP1 stimulates aldosterone production","volume":"22","author":"Jeon","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.steroids.2014.05.001_b0305","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1055\/s-0031-1284367","article-title":"ERK1\/2 MAPKs and Wnt signaling pathways are independently involved in adipocytokine-mediated aldosterone secretion","volume":"119","author":"Vleugels","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.steroids.2014.05.001_b0310","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.174235","article-title":"Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion","volume":"102","author":"Caprio","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.steroids.2014.05.001_b0315","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/en.2010-0925","article-title":"11beta-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe\u2013\/\u2013 mice","volume":"152","author":"Deuchar","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.05.001_b0320","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1043-2760(00)00301-5","article-title":"Adipose tissue as an endocrine organ","volume":"11","author":"Ahima","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.05.001_b0325","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1101\/gad.1779209","article-title":"Transcriptional control of brown adipocyte development and physiological function-of mice and men","volume":"23","author":"Seale","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.steroids.2014.05.001_b0330","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/35007527","article-title":"Towards a molecular understanding of adaptive thermogenesis","volume":"404","author":"Lowell","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2014.05.001_b0335","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2337\/diabetes.54.5.1385","article-title":"Uncoupling protein 1 is necessary for norepinephrine-induced glucose utilization in brown adipose tissue","volume":"54","author":"Inokuma","year":"2005","journal-title":"Diabetes"},{"issue":"Pt 4","key":"10.1016\/j.steroids.2014.05.001_b0340","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1242\/jcs.103.4.931","article-title":"Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization","volume":"103","author":"Cousin","year":"1992","journal-title":"J Cell Sci"},{"key":"10.1016\/j.steroids.2014.05.001_b0345","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0014-5793(84)80822-4","article-title":"Brown adipose tissue in the parametrial fat pad of the mouse","volume":"167","author":"Young","year":"1984","journal-title":"FEBS Lett"},{"key":"10.1016\/j.steroids.2014.05.001_b0350","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1172\/JCI3155","article-title":"Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity","volume":"102","author":"Guerra","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.05.001_b0355","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1172\/JCI62308","article-title":"Brown adipose tissue regulates glucose homeostasis and insulin sensitivity","volume":"123","author":"Stanford","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.05.001_b0360","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.05.001_b0365","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2337\/db09-0530","article-title":"High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity","volume":"58","author":"Saito","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.steroids.2014.05.001_b0370","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa0808718","article-title":"Cold-activated brown adipose tissue in healthy men","volume":"360","author":"van Marken Lichtenbelt","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.05.001_b0375","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1056\/NEJMoa0808949","article-title":"Functional brown adipose tissue in healthy adults","volume":"360","author":"Virtanen","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.05.001_b0380","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1172\/JCI1915","article-title":"Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action","volume":"101","author":"Zennaro","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.05.001_b0385","doi-asserted-by":"crossref","first-page":"E386","DOI":"10.1152\/ajpendo.2000.279.2.E386","article-title":"The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes","volume":"279","author":"Penfornis","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.05.001_b0390","doi-asserted-by":"crossref","first-page":"E640","DOI":"10.1152\/ajpendo.2001.280.4.E640","article-title":"Mineralocorticoid and glucocorticoid receptors inhibit UCP expression and function in brown adipocytes","volume":"280","author":"Viengchareun","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.05.001_b0395","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/en.2009-0869","article-title":"Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet","volume":"151","author":"Wada","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.05.001_b0400","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12272-013-0023-8","article-title":"Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes","volume":"36","author":"Lee","year":"2013","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.steroids.2014.05.001_b0405","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nri3071","article-title":"Macrophage-mediated inflammation in metabolic disease","volume":"11","author":"Chawla","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.steroids.2014.05.001_b0410","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.05.001_b0415","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cmet.2008.04.003","article-title":"Alternative M2 activation of Kupffer cells by PPAR delta ameliorates obesity-induced insulin resistance","volume":"7","author":"Odegaard","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.steroids.2014.05.001_b0420","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1172\/JCI31561","article-title":"Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones","volume":"117","author":"Hevener","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.05.001_b0425","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.109.131110","article-title":"Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone\/salt-induced cardiac fibrosis and increased blood pressure","volume":"54","author":"Rickard","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.05.001_b0430","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI41080","article-title":"Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice","volume":"120","author":"Usher","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.05.001_b0435","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1210\/en.2011-2098","article-title":"Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis","volume":"153","author":"Bienvenu","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.05.001_b0440","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1734-1140(13)70983-6","article-title":"Eplerenone promotes alternative activation in human monocyte-derived macrophages","volume":"65","author":"Labuzek","year":"2013","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.steroids.2014.05.001_b0445","doi-asserted-by":"crossref","first-page":"E1415","DOI":"10.1152\/ajpendo.00419.2013","article-title":"Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet","volume":"305","author":"Wada","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.05.001_b0450","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.mce.2011.06.038","article-title":"Aldosterone, mineralocorticoid receptor, and heart failure","volume":"350","author":"Messaoudi","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.steroids.2014.05.001_b0455","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature10653","article-title":"Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis","volume":"480","author":"Nguyen","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2014.05.001_b0460","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.176.1.287","article-title":"Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation","volume":"176","author":"Stein","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.steroids.2014.05.001_b0465","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.4049\/jimmunol.151.12.7151","article-title":"Modulation of murine macrophage function by IL-13","volume":"151","author":"Doherty","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.steroids.2014.05.001_b0470","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/eji.1830240630","article-title":"Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma","volume":"24","author":"Doyle","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.steroids.2014.05.001_b0475","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-immunol-032712-095906","article-title":"Interleukin-4-and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease","volume":"31","author":"Van Dyken","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.steroids.2014.05.001_b0480","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s001090050117","article-title":"STAT6: its role in interleukin 4-mediated biological functions","volume":"75","author":"Takeda","year":"1997","journal-title":"J Mol Med (Berl)"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14000981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14000981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:02:16Z","timestamp":1758535336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X14000981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":96,"alternative-id":["S0039128X14000981"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2014.05.001","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mineralocorticoid receptor in adipocytes and macrophages: A promising target to fight metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2014.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}